The cornerstone of precision oncology is the comprehensive analysis of the cancer genome. By sequencing the DNA of cancer cells, oncologists can identify specific mutations and pathways driving the disease. This genetic profiling can reveal targets for targeted therapies, such as kinase inhibitors, or help in selecting suitable patients for immunotherapy. Additionally, this approach can identify biomarkers that predict response to certain treatments, enabling a more focused therapy regimen.
